Microfluidics expands the zebrafish potentials in pharmaceutically relevant screening

Chia-Yuan Chen, Chao Min Cheng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The objective of this study is to enlarge the impact of microfluidics on the pharmaceutical industry by highlighting the reported scientific work on the synergistic relationship between zebrafish and microfluidics, and furthering that effort to shed light on how microfluidics can facilitate the use of zebrafish as a gene screening tool. Zebrafish is ranked the third most important animal model after rats and mice, according to a National Institutes of Health (NIH) announcement in 2003. It has become a staple for scientists to examine and subsequently begin to unravel the mystery of human diseases, and is increasingly used in toxicological studies for new drug development. The unique characteristics that this tiny fish possesses, including rapid growth rate, prodigious numbers of offspring, and eggs that develop outside the body, make it an invaluable genetic tool. Evidently, these advantages can be broadened with the addition of a properly designed microfluidic circuit. By means of the presented illustrations and demonstrated applications, the goal is to spark interest in the development of more novel microfluidic platform designs that can leverage the attributes of zebrafish and quickly come to commercial fruition.

Original languageEnglish
Pages (from-to)940-945
Number of pages6
JournalAdvanced Healthcare Materials
Volume3
Issue number6
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Microfluidics
Zebrafish
Screening
National Institutes of Health (U.S.)
Drug Industry
Electric sparks
Pharmaceutical Preparations
Drug products
Toxicology
Fish
Eggs
Rats
Fishes
Animals
Animal Models
Genes
Health
Networks (circuits)
Growth
Industry

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Biomaterials
  • Pharmaceutical Science
  • Medicine(all)

Cite this

@article{1a40fe11764e40088d9b326c6f48a43e,
title = "Microfluidics expands the zebrafish potentials in pharmaceutically relevant screening",
abstract = "The objective of this study is to enlarge the impact of microfluidics on the pharmaceutical industry by highlighting the reported scientific work on the synergistic relationship between zebrafish and microfluidics, and furthering that effort to shed light on how microfluidics can facilitate the use of zebrafish as a gene screening tool. Zebrafish is ranked the third most important animal model after rats and mice, according to a National Institutes of Health (NIH) announcement in 2003. It has become a staple for scientists to examine and subsequently begin to unravel the mystery of human diseases, and is increasingly used in toxicological studies for new drug development. The unique characteristics that this tiny fish possesses, including rapid growth rate, prodigious numbers of offspring, and eggs that develop outside the body, make it an invaluable genetic tool. Evidently, these advantages can be broadened with the addition of a properly designed microfluidic circuit. By means of the presented illustrations and demonstrated applications, the goal is to spark interest in the development of more novel microfluidic platform designs that can leverage the attributes of zebrafish and quickly come to commercial fruition.",
author = "Chia-Yuan Chen and Cheng, {Chao Min}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/adhm.201300546",
language = "English",
volume = "3",
pages = "940--945",
journal = "Advanced healthcare materials",
issn = "2192-2640",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

Microfluidics expands the zebrafish potentials in pharmaceutically relevant screening. / Chen, Chia-Yuan; Cheng, Chao Min.

In: Advanced Healthcare Materials, Vol. 3, No. 6, 01.01.2014, p. 940-945.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microfluidics expands the zebrafish potentials in pharmaceutically relevant screening

AU - Chen, Chia-Yuan

AU - Cheng, Chao Min

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The objective of this study is to enlarge the impact of microfluidics on the pharmaceutical industry by highlighting the reported scientific work on the synergistic relationship between zebrafish and microfluidics, and furthering that effort to shed light on how microfluidics can facilitate the use of zebrafish as a gene screening tool. Zebrafish is ranked the third most important animal model after rats and mice, according to a National Institutes of Health (NIH) announcement in 2003. It has become a staple for scientists to examine and subsequently begin to unravel the mystery of human diseases, and is increasingly used in toxicological studies for new drug development. The unique characteristics that this tiny fish possesses, including rapid growth rate, prodigious numbers of offspring, and eggs that develop outside the body, make it an invaluable genetic tool. Evidently, these advantages can be broadened with the addition of a properly designed microfluidic circuit. By means of the presented illustrations and demonstrated applications, the goal is to spark interest in the development of more novel microfluidic platform designs that can leverage the attributes of zebrafish and quickly come to commercial fruition.

AB - The objective of this study is to enlarge the impact of microfluidics on the pharmaceutical industry by highlighting the reported scientific work on the synergistic relationship between zebrafish and microfluidics, and furthering that effort to shed light on how microfluidics can facilitate the use of zebrafish as a gene screening tool. Zebrafish is ranked the third most important animal model after rats and mice, according to a National Institutes of Health (NIH) announcement in 2003. It has become a staple for scientists to examine and subsequently begin to unravel the mystery of human diseases, and is increasingly used in toxicological studies for new drug development. The unique characteristics that this tiny fish possesses, including rapid growth rate, prodigious numbers of offspring, and eggs that develop outside the body, make it an invaluable genetic tool. Evidently, these advantages can be broadened with the addition of a properly designed microfluidic circuit. By means of the presented illustrations and demonstrated applications, the goal is to spark interest in the development of more novel microfluidic platform designs that can leverage the attributes of zebrafish and quickly come to commercial fruition.

UR - http://www.scopus.com/inward/record.url?scp=84902288910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902288910&partnerID=8YFLogxK

U2 - 10.1002/adhm.201300546

DO - 10.1002/adhm.201300546

M3 - Article

VL - 3

SP - 940

EP - 945

JO - Advanced healthcare materials

JF - Advanced healthcare materials

SN - 2192-2640

IS - 6

ER -